CSS
AMED

Cubist Systematic Strategies’s Amedisys AMED Stock Holding History

Cubist Systematic Strategies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,291
Closed -$619K – 2981
2025
Q2 		$619K Sell
6,291
-25,542
-80% -$2.42M ﹤0.01% 2164
2025
Q1 		$2.95M Buy
+31,833
New +$2.93M 0.02% 1188
2024
Q4 		– Sell
-7,224
Closed -$697K – 2938
2024
Q3 		$697K Buy
+7,224
New +$705K ﹤0.01% 2042
2024
Q2 		– Sell
-14,874
Closed -$1.37M – 2922
2024
Q1 		$1.37M Buy
14,874
+10,126
+213% +$949K 0.01% 1914
2023
Q4 		$451K Buy
+4,748
New +$443K ﹤0.01% 2573
2023
Q2 		– Sell
-113,615
Closed -$9.32M – 3451
2023
Q1 		$8.36M Buy
113,615
+68,249
+150% +$5.9M 0.05% 557
2022
Q4 		$3.79M Sell
45,366
-10,057
-18% -$907K 0.02% 1275
2022
Q3 		$5.36M Sell
55,423
-5,610
-9% -$669K 0.03% 1015
2022
Q2 		$6.42M Buy
61,033
+53,426
+702% +$6.83M 0.04% 758
2022
Q1 		$1.31M Sell
7,607
-19,871
-72% -$2.97M 0.01% 1815
2021
Q4 		$4.45M Sell
27,478
-57,639
-68% -$9.26M 0.04% 738
2021
Q3 		$12.7M Buy
85,117
+55,858
+191% +$11.6M 0.16% 121
2021
Q2 		$7.17M Buy
29,259
+10,816
+59% +$2.84M 0.08% 351
2021
Q1 		$4.88M Buy
18,443
+11,096
+151% +$3.13M 0.06% 469
2020
Q4 		$2.15M Sell
7,347
-4,586
-38% -$1.18M 0.03% 898
2020
Q3 		$2.82M Sell
11,933
-11,133
-48% -$2.53M 0.04% 696
2020
Q2 		$4.58M Buy
23,066
+17,362
+304% +$3.24M 0.08% 390
2020
Q1 		$1.05M Sell
5,704
-21,316
-79% -$3.79M 0.03% 799
2019
Q4 		$4.51M Buy
+27,020
New +$4.02M 0.08% 348
2019
Q3 		– Sell
-11,696
Closed -$1.42M – 2195
2019
Q2 		$1.42M Buy
11,696
+9,886
+546% +$1.17M 0.03% 851
2019
Q1 		$223K Buy
+1,810
New +$227K 0.01% 1701
2018
Q4 		– Sell
-2,187
Closed -$273K – 2032
2018
Q3 		$273K Sell
2,187
-185
-8% -$20.4K 0.01% 1224
2018
Q2 		$203K Buy
2,372
+2,172
+1,086% +$159K 0.01% 1348
2018
Q1 		$12K Sell
200
-6,146
-97% -$350K ﹤0.01% 1768
2017
Q4 		$334K Buy
6,346
+5,044
+387% +$266K 0.02% 1175
2017
Q3 		$73K Buy
+1,302
New +$68.9K ﹤0.01% 1684
2016
Q2 		– Sell
-1,075
Closed -$52K – 1705
2016
Q1 		$52K Sell
1,075
-9,215
-90% -$356K ﹤0.01% 1473
2015
Q4 		$405K Sell
10,290
-920
-8% -$36.8K 0.02% 935
2015
Q3 		$426K Sell
11,210
-17,859
-61% -$753K 0.02% 1050
2015
Q2 		$1.16M Buy
+29,069
New +$906K 0.06% 491
2015
Q1 		– Sell
-11,944
Closed -$351K – 1874
2014
Q4 		$351K Buy
11,944
+7,132
+148% +$176K 0.02% 1105
2014
Q3 		$97K Buy
+4,812
New +$92.8K 0.01% 1547

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cubist Systematic Strategies's AMED Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,291 shares — an estimated $619K sold.

Cubist Systematic Strategies first reported a position in AMED in Q3 2014 and held it in 32 quarters. The position peaked at $12.7M in Q3 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,291 Amedisys shares in Q3 2025, an estimated $619K.
  • Cubist Systematic Strategies first reported a position in Amedisys in Q3 2014 and held it in 32 quarters.
  • Cubist Systematic Strategies's Amedisys position peaked at $12.7M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.